Those suffering from psoriasis are known to be at increased risk of cardiovascular disease like heart attack and stroke. A new treatment for psoriasis may also significantly decrease the cardiovascular risk. In the treatment, a compound known as adalimumab (sold as Humira ) is injected under the skin. The findings were presented at the annual meeting of the American Academy of Dermatology and showed that the treatment decreased skin damage and improved cardiovascular health indicators. Ask your dermatologist about psoriasis’ relation with cardiovascular disease. Robert Bissonn...

For people who suffer from the inflammatory skin disease psoriasis, their risks of a heart attack, stroke, or dying from cardiovascular disease are much higher.

Overweight children have a significantly higher prevalence of psoriasis - and they are also at higher risk for heart disease that starts in childhood with higher cholesterol levels.